alpha-aminopyridine has been researched along with Esophageal Reflux in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houwen, RHJ; Slae, M; van der Woerd, WL; Wilschanski, M | 1 |
| Aihara, T; Hirao, A; Kato, T; Kurebayashi, Y; Mori, H; Ochi, Y; Ohshiro, H; Sakakibara, M; Takahashi, N; Taniguchi, Y; Tonai-Kachi, H | 1 |
1 review(s) available for alpha-aminopyridine and Esophageal Reflux
| Article | Year |
|---|---|
Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Body Mass Index; Chloride Channel Agonists; Cystic Fibrosis; Digestive System; Drug Combinations; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Intestinal Diseases; Liver Diseases; Probiotics; Quinolones; Treatment Outcome; Weight Gain | 2017 |
1 other study(ies) available for alpha-aminopyridine and Esophageal Reflux
| Article | Year |
|---|---|
N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
Topics: Aminopyridines; Animals; Anti-Ulcer Agents; Benzopyrans; Disease Models, Animal; Dogs; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stomach; Swine | 2009 |